Cyprus vs Slovakia: HIV/AIDS deaths averted by antiretroviral therapy
Cyprus
64 deaths
in 2021
Slovakia
81.33 deaths
in 2024
Cyprus rank
131st
Slovakia rank
129th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cyprus
- Slovakia
How they compare
Slovakia currently reports 81.33 deaths against 64 deaths in Cyprus, a difference of 17.33 deaths.
That makes Slovakia's figure about 1.3 times Cyprus's.
The two have swapped places 1 time across 32 shared years of data; in 1990 it was Slovakia ahead.
Cyprus ranks 131st and Slovakia ranks 129th of 157 countries.
Across the 4 decades both report, Cyprus averaged higher in 3 and Slovakia in 1.
Head to head by decade
| Decade | Cyprus | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0.3745 deaths | 0.3745 deaths | Slovakia |
| 2000s | 11.5 deaths | 8.43 deaths | 3.07 deaths | Cyprus |
| 2010s | 42.1 deaths | 26.27 deaths | 15.83 deaths | Cyprus |
| 2020s | 63.5 deaths | 48.1 deaths | 15.4 deaths | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cyprus or Slovakia?
- Slovakia, at 81.33 deaths against 64 deaths in Cyprus as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cyprus and Slovakia?
- 17.33 deaths, with Slovakia ahead.
- How many years of comparable data are there for Cyprus and Slovakia?
- 32 years are reported by both, from 1990 to 2021.
- How do Cyprus and Slovakia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cyprus ranks 131st and Slovakia ranks 129th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.